A. Garaventa

S. Fanti, A. Piccardo, G. Villavecchia, 2013, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Interchangeability between 24‐hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma

Giorgio Reggiardo, A. Di Cataldo, A. Garaventa, 2013, Pediatric blood & cancer.

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

A Garaventa, S Parodi, R Haupt, 2013, European journal of cancer.

Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma

Giorgio Reggiardo, R. Haupt, A. Garaventa, 2012, OncoTargets and therapy.

Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.

N. Baldini, A. Garaventa, S. R. Baglio, 2011, Bone.

Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study

C. Nanni, S. Fanti, A. Pession, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.

Paolo D'Angelo, Alberto Garaventa, Claudio Gambini, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry.

S. Parodi, G. Tonini, A. Prete, 2009, European journal of cancer.

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Barbara Hero, Andreas Faldum, David Machin, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma levels of receptor activator of nuclear factor‐κB ligand and osteoprotegerin in patients with neuroblastoma

N. Baldini, A. Garaventa, P. Paolucci, 2006, International journal of cancer.

Peripheral Blood Stem Cell Tumor Cell Contamination and Survival of Neuroblastoma Patients

S. Parodi, V. Pistoia, R. Haupt, 2006, Clinical Cancer Research.

Second malignancies in children with neuroblastoma after combined treatment with 131I‐metaiodobenzylguanidine

C. Gambini, G. Villavecchia, A. Di Cataldo, 2003, Cancer.

A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma

G. Severi, A. Prete, R. Haupt, 2003, Cancer.

Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.

A. Donfrancesco, P. Bruzzi, G. Tonini, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

G. Tonini, B. Bernardi, L. Boni, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection Procedures for Neuroblastoma Cells Metastatic to Blood and Bone Marrow: Blinded Comparison of Chromogranin A Heminested Reverse Transcription Polymerase Chain Reaction to Tyrosine Hydroxylase Nested Reverse Transcription Polymerase Chain Reaction and to Anti-GD2 Immunocytology

G. Bussolati, A. Garaventa, L. Macri', 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases.

A. Donfrancesco, P. Bruzzi, M. Carli, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.

B. De Bernardi, A. Garaventa, M. Nantron, 2000, Medical and pediatric oncology.

In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategies.

G. Bernini, B. De Bernardi, A. Garaventa, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

B. Bernardi, E. Lanino, A. Garaventa, 2022 .

High-sensitivity immunocytologic analysis of neuroblastoma cells in paired blood and marrow samples.

B. Bernardi, G. Bernini, B. De Bernardi, 1998, Journal of hematotherapy.

Facing Thyroid Nodules in Paediatric Patients Previously Treated with Radiotherapy for Non-Thyroidal Cancers: Are Adult Ultrasound Risk Stratification Systems Reliable?

P. Trimboli, A. Piccardo, A. Garaventa, 2021, Cancers.

Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin’s disease

L. Guerra, S. Fanti, A. Pession, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Paraneoplastic cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma.

G. Bernardi, E. Lamantea, M. Truini, 2014, Functional neurology.

Malignant vascular tumors in children and adolescents: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group.

A. Ferrari, M. Carli, A. Garaventa, 2002, Medical and pediatric oncology.

Relationship between fenretinide pharmacokinetics, pharmacodynamics and plas ma retinol reduction in neuroblastoma patients

F. Formelli, R. Luksch, A. Garaventa, 2011 .

Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients

F. Formelli, R. Luksch, A. Garaventa, 2010, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide

F. Formelli, R. Luksch, A. Garaventa, 2008, Cancer Chemotherapy and Pharmacology.

Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR

B. Bernardi, C. Gambini, A. Garaventa, 2006, Clinical & Experimental Metastasis.

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma

V. Pistoia, A. Pezzolo, A. Garaventa, 2017, Cancer biology & therapy.

Anaplastic large cell lymphoma treated with a leukemia‐like therapy

M. Pillon, M. Comis, A. Garaventa, 2005, Cancer.

Congenital Myoepithelial Carcinoma of Soft Tissue Associated With Cystic Myoepithelioma

G. Morana, C. Alves, A. Garaventa, 2018, International journal of surgical pathology.

Italian Multicenter Study on Accuracy of 18F‐FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma

L. Guerra, A. Piccardo, G. Rubini, 2018, Clinical lymphoma, myeloma & leukemia.

Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

L. Boni, F. Formelli, M. Ponzoni, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Intraoperative bronchoscopy for bronchial carcinoid parenchymal-sparing resection: a pediatric case report

G. Mattioli, V. Jasonni, A. Garaventa, 2011, Pediatric Surgery International.

Treatment of Poor-Risk Neuroblastoma with Intensive Chemotherapy and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor

B. Bernardi, E. Lanino, L. Boni, 1992 .

The prognostic value of biological markers in paediatric Hodgkin lymphoma.

A. Pession, F. Locatelli, N. Santoro, 2016, European journal of cancer.

Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells

F. Zara, M. Delledonne, P. De Marco, 2021, International journal of molecular sciences.

Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients

A. Pezzolo, A. Garaventa, Martina Morini, 2020, Cancer biology & therapy.

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma Group

G. Tonini, A. Prete, R. Luksch, 2015, Pediatric blood & cancer.

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study ‖

S. Burchill, A. Cañete, A. Pezzolo, 2019, Cancers.

Correlation of killer-cell Ig-like receptor (KIR) haplotypes and Fcγ-receptor polymorphisms with survival of high-risk relapsed/refractory neuroblastoma patients treated by long-term infusion of anti-GD2 antibody ch14.18/CHO.

I. Yaniv, R. Ladenstein, A. Garaventa, 2016 .

Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma

L. Oneto, P. Uva, A. Garaventa, 2022, Frontiers in Oncology.

1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party.

T. Klingebiel, J. Zucker, F. Chauvin, 1997, European journal of cancer.

Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy

A. Pezzolo, A. Garaventa, M. Ognibene, 2019, International journal of molecular sciences.

Rhabdomyosarcoma in adolescents

A. Ferrari, M. Carli, A. Garaventa, 2012, Cancer.

Long‐term results of AIEOP LNH‐92 protocol for the treatment of pediatric lymphoblastic lymphoma: A report of the Italian Association of pediatric hematology and oncology

M. Pillon, A. Garaventa, Angelo Rosolen, 2009, Pediatric blood & cancer.

E. Lanino, A. Garaventa, M. Faraci, 2011, Pediatric transplantation.

Megatherapy combining I131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma

B. Bernardi, C. Bertolazzi, A. Garaventa, 2001, Bone Marrow Transplantation.

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.

G. Tonini, A. Anichini, M. Di Nicola, 2009, Cancer research.

Role of active follow‐up for early diagnosis of relapse after elective end of therapies

S. Parodi, R. Haupt, A. Garaventa, 2005, Pediatric blood & cancer.

Skeletal involvement in infants with neuroblastoma a quality control attempt.

S. Morbelli, C. Granata, G. Villavecchia, 2007, Tumori.

Skeletal Involvement in Infants with Neuroblastoma a Quality Control Attempt

S. Morbelli, C. Granata, G. Villavecchia, 2007 .

Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real‐life study

D. Zama, M. Moleti, M. Pillon, 2022, Pediatric blood & cancer.

Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: case reports with literature review.

C. Viscoli, A. Garaventa, E. Castagnola, 1997, The Journal of infection.

Generation of explicit rules predicting neuroblastoma patients’ outcome

R. Versteeg, A. Eggert, C. Gambini, 2012 .

Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility- complex-negative human tumour: neuroblastoma

P. Tasso, F. Ghiotto, V. Pistoia, 1996, Cancer Immunology, Immunotherapy.

Primary hypothyroidism as a consequence of 131 ‐I‐metaiodobenzylguanidine treatment for children with neuroblastoma

B. De Bernardi, A. Garaventa, M. Gattorno, 1995, Cancer.

Role of low-cost thyroid follow-up in children treated with radiotherapy for primary tumors at high risk of developing a second thyroid tumor.

A. Piccardo, A. Garaventa, G. Hanau, 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Diagnosis, Treatment Response, and Prognosis: The Role of 18F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with 123I-mIBG Scan: The First Prospective Study

M. Lattuada, A. Piccardo, G. Morana, 2019, The Journal of Nuclear Medicine.

Simultaneous Occurrence of Pancreatoblastoma and Neuroblastoma in a Newborn With Beckwith-Wiedemann Syndrome

V. Capra, C. Granata, A. Garaventa, 2010, Journal of pediatric hematology/oncology.

Outcome of children with relapsed or refractory neuroblastoma: A meta‐analysis of ITCC/SIOPEN European phase II clinical trials

X. Paoletti, B. Geoerger, G. Vassal, 2017, Pediatric blood & cancer.

Multimodality imaging of Hodgkin disease and non-Hodgkin lymphomas in children.

C. Granata, P. Tomà, A. Rossi, 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer

P. Bruzzi, L. Boni, C. Viscoli, 2003, The Pediatric infectious disease journal.

Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines.

G. Dini, A. Garaventa, G. Rossi, 1997, The European respiratory journal.

A proportion of patients with lymphoma may harbor mutations of the perforin gene.

R. Clementi, A. Pession, L. Dupré, 2004, Blood.

Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants

A. Garaventa, C. Bottino, R. Castriconi, 2022, Cancers.

Treatment of EBV‐Related Post‐Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV‐Specific T Cells

G. Botti, F. Baldanti, F. Locatelli, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations

M. Capasso, F. Pastorino, C. Brignole, 2022, International journal of molecular sciences.

Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

M. Cilli, S. Bruno, Genny Del Zotto, 2021, Journal of experimental & clinical cancer research : CR.

Clostridium difficile-associated disease in children with solid tumors

A. Garaventa, E. Castagnola, M. Nantron, 2009, Supportive Care in Cancer.

Specific pathways to prevent SARS‐CoV‐2 infection in case of repeated hospital admissions for radiotherapy

M. Garrè, C. Dufour, A. Garaventa, 2020, Pediatric blood & cancer.

Specific polymorphisms of cytokine genes are associated with different risks to develop single‐system or multi‐system childhood Langerhans cell histiocytosis

M. Martinetti, M. Cuccia, M. Aricò, 2006, British Journal of Haematology.

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

C. Viscoli, A. Garaventa, E. Castagnola, 1996, European journal of cancer.

Is chemotherapy effective therapy for intracranial immature teratoma?: A case report

M. Garrè, U. Göbel, B. De Bernardi, 1996 .

Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin

G. Ghiggeri, G. Caridi, C. Gambini, 2009, Pediatric Nephrology.

Non-ALC peripheral T-cell lymphomas in children: report on two cases and review of the literature.

M. Massimino, R. Giardini, R. Luksch, 2000, Haematologica.

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients

P. Glander, R. Kunert, V. Pistoia, 2013, mAbs.

Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.

C. Gambini, A. Garaventa, C. Panarello, 2001, Medical and pediatric oncology.

Treatment of advanced neuroblastoma with i‐131 meta‐iodobenzylguanidine

E. Lanino, B. De Bernardi, A. Garaventa, 1991, Cancer.

Prospective Evaluation of Different Methods for Volumetric Analysis on [18F]FDG PET/CT in Pediatric Hodgkin Lymphoma

A. Piccardo, E. Borsatti, A. Garaventa, 2022, Journal of clinical medicine.

131I‐Meta‐iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high‐risk neuroblastoma

E. Lanino, A. Piccardo, A. Garaventa, 2020, Pediatric blood & cancer.

High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma. The European Group for Bone Marrow Transplantation.

C. Lasset, T. Philip, R. Ladenstein, 1993, European journal of cancer.

Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials

R. Ladenstein, A. Garaventa, H. Lode, 2022, Cancers.

Clonal analysis of peripheral blood lymphocytes from three patients with advanced neuroblastoma receiving recombinant interleukin-2 and interferon α

E. Lanino, V. Pistoia, A. Garaventa, 2005, Cancer Immunology, Immunotherapy.

Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma

S. Fanti, A. Piccardo, G. Morana, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

‘High dose’ cisplatinum: a phase II study

B. Bernardi, G. Dini, E. Lanino, 1987 .

Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.

P. Cornaglia-Ferraris, G. Dini, E. Lanino, 1987, Medical and pediatric oncology.

Prophylaxis of streptococcal bacteraemia with oral penicillin V in children undergoing bone marrow transplantation

G. Dini, E. Lanino, C. Viscoli, 1995, Supportive Care in Cancer.

Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues

F. Zara, V. Capra, M. Iacomino, 2022, Birth defects research.

Nucleolin expression has prognostic value in neuroblastoma patients

D. Ribatti, R. Tamma, F. Pastorino, 2022, EBioMedicine.

Investigational drugs in phase II clinical trials for the treatment of neuroblastoma

M. Ponzoni, R. Haupt, A. Garaventa, 2017, Expert opinion on investigational drugs.

Trisomy 17 in congenital plexiform (multinodular) cellular schwannoma.

A. Garaventa, A. Sementa, E. Tassano, 2010, Cancer genetics and cytogenetics.

Chromosomal imbalances in pediatric Burkitt-like lymphoma and review of the literature in relation to other germinal center derived B-cell tumors

V. Pistoia, F. Parodi, C. Gambini, 2006, Leukemia & lymphoma.

Herpes simplex virus and oral mucositis in children with cancer

G. Dini, P. Argenta, R. Haupt, 1994, Supportive Care in Cancer.

Bone marrow transplantation for neuroblastoma : a review of 509 cases

G. Dini, E. Lanino, F. Chauvin, 1989 .

Increase of metaiodobenzylguanidine uptake and intracellular half‐life during differentiation of human neuroblastoma cells

M. Ponzoni, A. Garaventa, L. Raffaghello, 1996, International journal of cancer.

Retinol (vitamin A) and retinal-binding protein serum levels in children with cancer at onset.

P. Cornaglia-Ferraris, C. Dufour, A. Garaventa, 1997, Nutrition.

Diffuse bone and soft tissue angiomatosis with GNAQ mutation

A. Franchi, C. Mazzanti, A. Garaventa, 2020, Pathology international.

Conservative management of chylous ascites after oncological surgery for peripheral neuroblastic tumors in pediatric patients.

F. Boccardo, G. Mattioli, C. Granata, 2019, Lymphology.

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors.

F. Locatelli, A. Pession, A. Prete, 1999, Medical and pediatric oncology.

CT of invasive pulmonary aspergillosis in children with cancer

C. Viscoli, A. Garaventa, L. Manfredini, 2005, Pediatric Radiology.

Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An 18F‐DOPA PET study

F. Bini, F. Marinozzi, A. Piccardo, 2022, Pediatric blood & cancer.

Synovial sarcoma of children and adolescents: the prognostic role of axial sites.

A. Ferrari, M. Carli, R. Alaggio, 2008, European journal of cancer.

Home care for children following haematopoietic stem cell transplantation

G. Dini, A. Garaventa, G. Morreale, 2003, Bone Marrow Transplantation.

Feasibility of a home care program in a pediatric hematology and oncology department. Results of the first year of activity at a single Institution.

G. Dini, R. Haupt, A. Garaventa, 2002, Haematologica.

Detection of Neuroblastoma Cells in Bone Marrow and Peripheral Blood by Different Techniques

F. Callea, G. Tonini, P. Scaruffi, 2004, Clinical Cancer Research.

Infection withFusarium species in two children with neuroblastoma

C. Viscoli, A. Garaventa, E. Castagnola, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

Primary intestinal mold infection in children with solid tumors: a case report in an adolescent with Ewing sarcoma, and literature review.

C. Granata, A. Garaventa, E. Castagnola, 2016, The new microbiologica.

Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10‐year experience in a tertiary Italian centre

C. Viscoli, A. Garaventa, M. Faraci, 2017, Mycoses.

Role of Broviac catheters in infections in children with cancer.

B. Bernardi, G. Dini, L. Boni, 1988, The Pediatric infectious disease journal.

Early onset of Pneumocystis carinii pneumonia in a patient receiving bone marrow transplantation from a matched unrelated donor.

G. Dini, A. Garaventa, G. Rossi, 1994, Bone marrow transplantation.

Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary infiltrates after BMT in children.

G. Dini, E. Lanino, A. Garaventa, 1996, Bone marrow transplantation.

Changing pattern of pathogens causing broviac catheter-related bacteraemias in children with cancer.

C. Viscoli, A. Garaventa, E. Castagnola, 1995, The Journal of hospital infection.

Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)

M. Gaze, U. Pötschger, T. Trahair, 2020, Cancers.

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.

Ruth Ladenstein, Henrik Schroeder, Ulrike Pötschger, 2018, The Lancet. Oncology.

Survival after fungemia due toFusarium moniliforme in a child with neuroblastoma

C. Viscoli, A. Garaventa, E. Castagnola, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature

E. Fulcheri, A. Garaventa, M. Valenzano Menada, 2010, Melanoma research.

Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers

M. Carli, R. Alaggio, A. Di Cataldo, 2006, Cancer.

Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.

D. Frappaz, S. Burdach, T. Klingebiel, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry.

S. Parodi, R. Haupt, R. Luksch, 2009, European journal of cancer.

The unusual association between Neuroblastoma and Gaucher Disease: Case report and review of the literature.

M. Di Rocco, A. Garaventa, A. Sementa, 2018, Blood cells, molecules & diseases.

Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients

M. Capasso, A. Pezzolo, A. Di Cataldo, 2019, Genes, chromosomes & cancer.

Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma

G. Tonini, S. Bonassi, P. Scaruffi, 2009, BMC Cancer.

Salvage rates and prognostic factors after relapse in children and adolescents with malignant peripheral nerve sheath tumors

A. Ferrari, R. Alaggio, A. Garaventa, 2018, Pediatric blood & cancer.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification

A. Vicha, S. Parodi, G. Tonini, 2014, British Journal of Cancer.

Second Malignancies in Children Following Treatment for Neuroblastoma

B. Bernardi, A. Garaventa, 2014 .

Identification of GALNT14 as a novel neuroblastoma predisposition gene

M. Chierici, G. Tonini, S. Ferrini, 2015, Oncotarget.

Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study

G. Schleiermacher, T. Trahair, R. Luksch, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma

A. Quattrone, A. Iolascon, M. Capasso, 2020, Journal of cellular and molecular medicine.

Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial

T. Klingebiel, R. Ladenstein, A. Garaventa, 2018, Cancers.

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO

N. Hosten, S. Endres, R. Ladenstein, 2017, mAbs.

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

Günter Schreier, Ruth Ladenstein, Henrik Schroeder, 2017, The Lancet. Oncology.

High risk neuroblastoma: Small steps towards cure

A. Garaventa, 2014, Pediatric blood & cancer.

Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion.

I. Lewis, U. Pötschger, W. Holter, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Video-Assisted Needle Core Biopsy in Children Affected by Neuroblastoma: A Novel Combined Technique

G. Mattioli, C. Granata, A. Garaventa, 2016, European Journal of Pediatric Surgery.

Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors

G. Tonini, V. Pistoia, A. Pistorio, 2012, Pediatric blood & cancer.

High risk neuroblastoma: A persistent therapeutic challenge

G. Perilongo, A. Garaventa, 2008, Pediatric blood & cancer.

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

D. Frappaz, T. Klingebiel, F. Chauvin, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.

G. Dini, E. Lanino, A. Pession, 1996, Bone marrow transplantation.

Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.

G. Dini, E. Lanino, C. Viscoli, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma

P. Uva, A. Garaventa, D. Cangelosi, 2021, Cancers.

Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology

M. D. De Ioris, M. Capasso, F. Pastorino, 2023, Cancers.

Retrospective study of childhood ganglioneuroma.

P. Bruzzi, G. Tonini, C. Gambini, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming

M. Muselli, A. Garaventa, D. Cangelosi, 2020, Cancers.

MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma

S. Parodi, G. Tonini, A. Inga, 2010, Pediatric blood & cancer.

Cytogenetic characterization of a fibrous hamartoma of infancy with complex translocations.

A. Garaventa, E. Tassano, C. Morerio, 2010, Cancer genetics and cytogenetics.

Italian Guidelines for the Management of Infectious Complications in Pediatric Oncology: Empirical Antimicrobial Therapy of Febrile Neutropenia

G. Masera, C. Viscoli, N. Santoro, 1998, Oncology.

Does N-myc amplification correlate with other prognostic factors in advanced neuroblastoma? Preliminary results.

G. Tonini, P. Cornaglia-Ferraris, R. Sansone, 1986, Pediatric Hematology & Oncology.

Detection of Transplacental Melanoma Metastasis Using Quantitative PCR

V. Capra, R. Biassoni, A. Raso, 2010, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

perforin gene A proportion of patients with lymphoma may harbor mutations of the

A. Pession, L. Dupré, F. Locatelli, 2013 .

Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

B. Bernardi, M. Barchitta, A. Agodi, 2016, Clinical and Translational Oncology.

Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma.

C. Dominici, R. Haupt, R. Luksch, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.

Ruth Ladenstein, Jérôme Couturier, Victoria Castel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stages

M. Borrello, G. Tonini, B. Bernardi, 1993, International journal of cancer.

High-dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma.

G. Dini, E. Lanino, F. Chauvin, 1993, European journal of cancer.

European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.

M. Carli, E. Koscielniak, O. Oberlin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A novel pediatric case of cutaneous pre-B lymphoblastic lymphoma.

S. Zupo, A. Garaventa, A. Sementa, 2001, Haematologica.

G-CSF primed peripheral blood progenitor cells (PBPC) autotransplantation in stage IV Neuroblastoma and poor risk solid tumors.

G. Dini, E. Lanino, R. Rondelli, 1996, Bone marrow transplantation.

The role of BMT for neuroblastoma relapse patients. A report of the EBMT-STR.

D. Frappaz, J. Zucker, F. Chauvin, 1991, Bone marrow transplantation.

Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.

G. Dini, E. Lanino, L. Boni, 1991, Bone marrow transplantation.

Listeria monocytogenes brain abscesses in a girl with acute lymphoblastic leukaemia after late central nervous system relapse.

C. Viscoli, A. Garaventa, A. Taccone, 1991, European journal of cancer.

A short-term in vitro drug sensitivity assay in pediatric malignancies.

B. De Bernardi, A. Garaventa, C. Rosanda, 1987, Anticancer research.

Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry.

F. Chauvin, R. Ladenstein, A. Garaventa, 1994, Medical and pediatric oncology.

Tuberculosis diagnosed after chemotherapy for presumed mediastinal malignant neoplasia

C. Granata, A. Garaventa, E. Castagnola, 2014, Pediatric blood & cancer.

Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature

S. Parodi, G. Tonini, S. Bonassi, 2012, Pediatric blood & cancer.

Epithelioid sarcoma in children and adolescents

A. Ferrari, A. Gronchi, M. Carli, 2006, Cancer.

Sequential intensified chemotherapy with stem cell rescue for children and adolescents with desmoplastic small round-cell tumor

A. Ferrari, M. Carli, R. Alaggio, 2010, Bone Marrow Transplantation.

Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma

A. Donfrancesco, A. Ferrari, M. Carli, 2005, Cancer.

Metastatic tumors in the breast: sonographic findings.

G. Dini, G. Rizzatto, G. Giuseppetti, 1985, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience

S. Parodi, M. Pillon, R. Haupt, 2022, Cancers.

Laparoscopic resection of adrenal neuroblastoma without image-defined risk factors: a prospective study on 21 consecutive pediatric patients

G. Mattioli, C. Granata, A. Garaventa, 2014, Pediatric Surgery International.

Granulocytic Sarcoma Presenting as an Isolated Mediastinal Mass

B. Bernardi, A. Garaventa, C. Rosanda, 1989, Acta paediatrica Scandinavica.

Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants

F. Locatelli, A. Garaventa, D. Cangelosi, 2021, Journal for ImmunoTherapy of Cancer.

Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees

A. Ferrari, R. Luksch, A. Garaventa, 2012, BMC Cancer.

Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry.

D. Galimberti, A. Andreano, M. Valsecchi, 2019, European journal of cancer.

Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation

G. Dini, E. Lanino, A. Garaventa, 2000, Bone Marrow Transplantation.

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

R. Haupt, R. Luksch, R. Ladenstein, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

18F-DOPA PET/CT in Neuroblastoma: Comparison of Conventional Imaging With CT/MR

C. Nanni, S. Fanti, A. Pession, 2012, Clinical nuclear medicine.

Minimal disseminated disease in high-risk Burkitt's lymphoma identifies patients with different prognosis.

M. Aricò, M. Pillon, L. Lo Nigro, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is chemotherapy effective therapy for intracranial immature teratoma? A case report.

M. Garrè, U. Göbel, B. De Bernardi, 1996, Cancer.

Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy

S. Pileri, F. Locatelli, V. Vecchi, 2018, Leukemia & lymphoma.

Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.

A. Donfrancesco, L. Boni, M. Carli, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.

M. Carli, B. De Bernardi, A. Garaventa, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of integrated home/hospital physiotherapeutic support for children with cancer

G. Dini, A. Garaventa, M. Miano, 2006, Supportive Care in Cancer.

Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group

A. Ferrari, M. Carli, A. Garaventa, 2004, Cancer.

Early deaths in children after BMT

G. Dini, G. Meloni, F. Bonetti, 1992 .

FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial

L. Guerra, A. Piccardo, E. Borsatti, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Growth and endocrine assessment in children undergoing bone marrow transplant: the 'G. Gaslini' experience.

G. Dini, E. Lanino, A. Garaventa, 1991, Bone marrow transplantation.

Complete Posterior Sagittal Anorectal Mobilization (PSAM): A new surgical approach for pediatric pelvic‐perineal tumor resections

A. Garaventa, S. Avanzini, G. Martucciello, 2018, Journal of surgical oncology.

Successful treatment of Neuroblastoma in an adolescent with intra-arterial embolization before surgery

C. Gandolfo, G. Mattioli, C. Granata, 2017 .

Risk stratification of high‐risk metastatic neuroblastoma: A report from the HR‐NBL‐1/SIOPEN study

Ruth Ladenstein, Gudrun Schleiermacher, Ulrike Pötschger, 2018, Pediatric blood & cancer.

Detection of cell‐free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA

P. Scaruffi, V. Pistoia, A. Pistorio, 2010, Pediatric blood & cancer.

Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience

E. Bertini, C. Palermo, M. Pane, 2017, Neuromuscular Disorders.

Pediatric Extraskeletal Ewing Sarcoma Originating in the Heart: A Case Report and Review of the Literature.

A. Garaventa, N. Stagnaro, A. Sementa, 2021, Journal of pediatric hematology/oncology.

Multiple inflammatory fibrosarcoma of the abdominal cavity in a child.

A. Garaventa, E. Castagnola, M. Conte, 1996, Medical and pediatric oncology.

Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients

M. Muselli, R. Versteeg, A. Eggert, 2013, BMC Bioinformatics.

Antibiotic prophylaxis in children undergoing abdominal surgery for neoplastic diseases.

G. Mattioli, A. Garaventa, E. Castagnola, 2018, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Glutathione S-transferase polymorphisms and susceptibility to neuroblastoma

G. Tonini, L. Boni, R. Haupt, 2005, Pharmacogenetics and genomics.

Brain Metastasis from Neuroblastoma Depicted by 18F-DOPA PET/CT

A. Piccardo, G. Morana, A. Garaventa, 2015, Nuclear medicine and molecular imaging.

Non‐Hodgkin lymphoma in children with an associated inherited condition: A retrospective analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)

G. Basso, N. Santoro, M. Aricò, 2015, Pediatric blood & cancer.

Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.

A. Piccardo, G. Villavecchia, A. Garaventa, 2014, Clinical nuclear medicine.

Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study

R. Consolini, F. Locatelli, C. Fusco, 2021 .

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma

S. Parodi, M. Ponzoni, A. Moretta, 2018, Oncoimmunology.

Biopsy or debulking surgery as initial surgery for locally advanced rhabdomyosarcomas in children?

A. Ferrari, M. Carli, A. Garaventa, 2007, Cancer.

Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin

G. Dini, E. Lanino, A. Garaventa, 2004, Cancer Chemotherapy and Pharmacology.

Classical pediatric Hodgkin lymphoma in very young patients: the Italian experience

F. Locatelli, A. Pession, M. Vetro, 2018, Leukemia & lymphoma.

Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?

U. Ficola, M. Pillon, A. Garaventa, 2016, Cancer medicine.

Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.

Giorgio Reggiardo, A. Garaventa, S. Sorrentino, 2014, Clinical biochemistry.

Long‐term results of the AIEOP LNH‐97 protocol for childhood lymphoblastic lymphoma

G. Basso, N. Santoro, M. Aricò, 2015, Pediatric blood & cancer.

Pneumonia due to Mycoplasma pneumoniae in granulocytopenic children with cancer

L. Banov, C. Dufour, A. Garaventa, 2009, Pediatric blood & cancer.

Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma

S. Parodi, R. Haupt, A. Garaventa, 2008, British Journal of Cancer.

Early infectious complications in children undergoing BMT.

G. Dini, E. Lanino, L. Boni, 1991, Bone marrow transplantation.

A randomized study of the empirical antibiotic therapy of the infections in neutropenic patients, affected by neoplastic diseases in paediatric age and under a fever attack

G. Dini, L. Boni, C. Viscoli, 1987 .

Comparison of Hodgkin’s Lymphoma in Children and Adolescents. A Twenty Year Experience with MH’96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols

D. Galimberti, E. Sabattini, R. Rondelli, 2020, Cancers.

Long‐term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B‐cell non‐Hodgkin lymphoma (AIEOP LNH92)

M. Pillon, A. Di Cataldo, M. Putti, 2004, Cancer.

Osteogenesis Imperfecta/Ehlers–Danlos Overlap Syndrome and Neuroblastoma—Case Report and Review of Literature

M. Maghnie, V. Capra, M. Capasso, 2022, Genes.

Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.

E. Lanino, B. De Bernardi, A. Garaventa, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Umbilical cord blood transplantation: should perinatal solid cancer become a matter of concern?

V. Pistoia, R. Haupt, A. Garaventa, 2008, Journal of the National Cancer Institute.

High dose peptichemio in pretreated neuroblastoma.

B. De Bernardi, A. Garaventa, G. Pastore, 1989, Anticancer research.

Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B‐Cell Lymphoma treated with the AIEOP LNH‐97 protocol

G. Basso, N. Santoro, M. Aricò, 2016, British journal of haematology.

Neuroblastoma IV‐S in a patient with bilateral microphthalmia

A. Garaventa, Riccardo Haupt, A. Dolci, 1993, Acta paediatrica.

Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.

M. Nigro, B. De Bernardi, A. Garaventa, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Rhinopharyngeal B-cell non-hodgkin lymphoma: unusual presentation with massive hematemesis.

C. Gambini, A. Barabino, A. Garaventa, 2007, Pediatric emergency care.

Nusinersen versus Sham Control in Infantile‐Onset Spinal Muscular Atrophy

R. J. Ramamurthi, S. Y. Kim, H. Y. Wang, 2017, The New England journal of medicine.

Winners' Cup: A National Football Tournament Brings Together Adolescent Patients with Cancer from all over Italy

A. Ferrari, M. Massimino, Teresa Perillo, 2017, Tumori.

Fatal pneumopathy in children after bone marrow transplantation--report from the Italian Registry. Italian Association of Pediatric Hematology-Oncology BMT Group.

F. Locatelli, R. Miniero, R. Rondelli, 1995, Bone marrow transplantation.

Phase II study of recombinant human granulocyte colony-stimulating factor in children undergoing bone marrow transplantation.

G. Dini, E. Lanino, A. Pession, 1996, Bone marrow transplantation.

Computational intelligence analysis of high-risk neuroblastoma patient health records reveals time to maximum response as one of the most relevant factors for outcome prediction.

D. Chicco, P. Uva, R. Luksch, 2023, European journal of cancer.